Endometrial adenocarcinoma: An analysis of treatment and outcome

Oncology Reports

Volumn 20, Issue 5, 2008, Pages 1221-1228

  Byrd, Louise M ^a   Swindell, Richard ^b   Webber Rookes, Daniel ^b   Hannon, R ^b   Hunter, Robin D ^b   Livsey, Jac ^b   Davidson, Susan E ^b  

^a ST MARY S HOSPITAL   (United Kingdom)

^b CHRISTIE HOSPITAL   (United Kingdom)

Author keywords

Co morbidity; Endometrial adenocarcinoma; Outcome; Survival; Treatment

Indexed keywords

CESIUM 137;

ABDOMINAL HYSTERECTOMY; ADULT; AGE; AGED; BRACHYTHERAPY; CANCER ADJUVANT THERAPY; CANCER GRADING; CANCER STAGING; CANCER SURVIVAL; CAUSE OF DEATH; COMORBIDITY; CONTROLLED STUDY; DISEASE SEVERITY; ENDOMETRIUM CARCINOMA; ENTEROPATHY; EXTERNAL BEAM RADIOTHERAPY; FEMALE; HEART FAILURE; HEART INFARCTION; HUMAN; INCIDENCE; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; MORBIDITY; OVERALL SURVIVAL; PATIENT REFERRAL; PELVIS LYMPH NODE; PNEUMONIA; PRIORITY JOURNAL; REVIEW; SALPINGOOOPHORECTOMY; STROKE; TREATMENT OUTCOME; VAGINA DISEASE; ADENOCARCINOMA; ADJUVANT THERAPY; ARTICLE; ENDOMETRIUM TUMOR; GYNECOLOGIC SURGERY; KAPLAN MEIER METHOD; METHODOLOGY; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; RADIOTHERAPY;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; BRACHYTHERAPY; COMBINED MODALITY THERAPY; ENDOMETRIAL NEOPLASMS; FEMALE; GYNECOLOGIC SURGICAL PROCEDURES; HUMANS; KAPLAN-MEIERS ESTIMATE; MIDDLE AGED; RADIOTHERAPY; RADIOTHERAPY, ADJUVANT; TREATMENT OUTCOME;

EID: 58149347724     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or_00000133     Document Type: Review

References (32)

1. Visser O, Coebergh JWW, Schouten LJ and Van Dijk JAAM: Incidence of cancer in the Netherlands 1995. Utrect: Netherlands Cancer Registry, 43, 1998.
2. Jereczek-Fossa BA, Badzio A and Jassem J: Surgery followed by radiotherapy in endometrial cancer: Analysis of survival and patterns of failure. Int J Gynecol Cancer 9: 285-294, 1999.
3. Roberts JA, Brunetto VL, Keys HM, et al: A phase III randomised study of surgery versus surgery plus adjuvant radiation therapy in intermediate-risk endometrial carcinoma (GOG 99). Soc Gynecol Oncol 99: 70, 1998.
4. Fishman D, Roberts K, Chambers J, et al: Radiation therapy as exclusive treatment for medically inoperable patients with stage I and II endometrial carcinoma. Gynecol Oncol 61:189-196, 1996.
5. Chassagne D, Sismondi P, Horiot JC, Sinistrero G, Bey P, Zola P, Pernot M, Gerbaulet A, Kunkler I and Michel G: A glossary for reporting complications of treatment in gynaecological cancers. Radiat Oncol 26: 195-202, 1993.
6. Charlson ME, Pompei P, Ales KL and MacKenzie CR: A new method for classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis 40: 373-383, 1987.
7. Linn BS, Linn MW and Gurel L: Cumulative illness rating scale. J Am Geriatr Soc 16: 622-626, 1968.
8. Greenfield S, Apolone G, McNeil BJ and Cleary PD: The importance of co-existent disease in the occurrence of post-operative complications and one year recovery in patients undergoing total hip replacement. Comorbidity and outcomes after hip replacement. Med Care 31: 141-154, 1993.
9. Kaplan MH and Feinstein AR: The importance of classifying initial co-morbidity in evaluating the outcome in diabetes mellitus. J Chron Dis 27: 387-404, 1974.
10. Peto R, Pike MC, Armitage P, Breslaw NE, Cox DR, Howard SV, et al: Design and analysis of randomised clinical trials requiring prolonged observation of each patient. II Analysis and examples. Br J Cancer 35: 1-39, 1977.
11. FIGO annual report on the results of treatment in gynaecological cancer. Int J Gynecol Obstet 83: 1-229, 2003.
12. Steiner E, Eicher O, Sagemuller J, Schmidt M, Pilch H, Tanner B, et al: Multivariate independent prognostic factors in endometrial carcinoma: A clinicopathologic study in 181 patients: 10 years experience at the Department of Obstetrics and Gynecology of the Mainz University. Int J Gynecol Cancer 13: 197-203, 2003.
13. Troung PT, Kader HA, Lucy B, Lesperance M, MacNeil MV, Berthelet E, et al: The effect of age and co-morbidity on treatment and outcome in women with endometrial cancer. Am J Clin Oncol 28: 157-164, 2005.
14. Alektiar KM, Venkatraman E, Abu-Rustum N, et al: Is endometrial carcinoma intrinsically more aggressive in elderly patients? Cancer 98: 2368-2377, 2003.
15. Jereczek-Fossa BA, Badzio A and Jassem J: Factors determining acute normal tissue reactions during postoperative radiotherapy in endometrial cancer: analysis of 317 consecutive cases. Radiat Oncol 68: 33-39, 2003.
16. Aalders J, Abeler V, Kolstad P and Onsrud M: Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma: clinical and histopathological study of 540 patients. Obstet Gynecol 56: 419-427, 1980.
17. Creutzberg CL, van Putten WL, Koper PC, et al: Surgery and postoperative radiotherapy versus surgery alone for patients with stage I endometrial carcinoma: Multicentre randomised trial-PORTEC study group, post operative radiation therapy in endometrial carcinoma. Lancet 355: 1404-1411, 2000.
18. Sartori E, Laface B, Gadducci A, Maggino T, Zola P, Landoni F and Zanagnolo V: Factor's influencing survival in endometrial cancer relapsing patients: a cooperation task force (CTF) study. Int J Gynecol Cancer 13: 458-465, 2003.
19. Ackerman I, Malone S, Thomas G, et al: Endometrial carcinoma: Relative effectiveness of adjuvant irradiation versus therapy reserved for relapse. Gynecol Oncol 60: 177-183, 1996.
20. Jereczek-Fossa BA, Badzio A and Jassem J: Recurrent endometrial cancer after surgery alone: results of salvage radiotherapy. Int J Radiat Oncol Biol Phys 48: 405-413, 2000.
21. Burke TW, Gerhenson DM, Morris M, Stringer CA, Levenback C, Tortolero-Luna G and Baker VV: Postoperative adjuvant cisplatin, doxorubicin, and cyclophosphamide (PAC) chemotherapy in women with high-risk endometrial carcinoma. Gynecol Oncol 55: 47-50, 1994.
22. Aoki Y, Watanabe M, Amikura T, Obata H, Sekine M, Yahata T, et al: Adjuvant chemotherapy as treatment of high risk stage I and II endometrial cancer. Gynecol Oncol 94: 333-339, 2004.
23. Weiss E, Hirnle P, Arnold-Bofinger H, Hess CF and Bamberg M: Therapeutic outcome and relation of acute and late side effects in the adjuvant radiotherapy of endometrial stage I and II. Radiat Oncol 53: 37-44, 1999.
24. Rittenberg PVC, Lotocki RJ, Heywood MS, Jones KD and Krepart GV: High-risk surgical stage I endometrial cancer: outcomes with vault brachytherapy alone. Gynecol Oncol 89: 288-294, 2003.
25. Chadha M, Nanavati PJ, Liu P, Fanning J and Jacobs A: Patterns of failure in endometrial carcinoma stage 1B grade 3 and IC patients treated with postoperative vaginal vault brachytherapy. Gynecol Oncol 75: 103-107, 1999.
26. Creutzberg CL, van Putten WLJ, Koper PC, Lybeert MLM, Jobsen JJ, Warlam-Rodenhuis CC, et al: The morbidity of treatment for patients with stage I endometrial cancer: results from a randomised trial. Int J Radiat Oncol Biol Phys 51: 1246-1255, 2001.
27. Lancaster L: Preventing vaginal stenosis after brachytherapy for gynaecological cancer: an overview of Australian practices. Eur J Oncol Nurs 8: 30-39, 2004.
28. Soler M, Chatenoud L, Negri E, Parazzini F, Franceschi S and Vecchia CL: Hypertension and hormone-related neoplasm. Hypertension 34: 320-325, 1999.
29. Anderson KE, Anderson E, Mink PJ, et al: Diabetes and endometrial cancer in the Iowa women's health study. Cancer Epidemiol Biomarkers Prev 10: 611-616, 2001.
30. Mariani A, Webb MJ, Keeney GL, et al: Surgical stage I endometrial cancer: predictors of distant failure and death. Gynecol Oncol 87: 274, 2002.
31. Wang CJ, Leung SW, Chen HC, et al: The correlation of acute toxicity and late rectal injury in radiotherapy for cervical carcinoma: evidence suggestive of consequential late effect (CQLE). Int J Radiat Oncol Biol Phys 40: 85-91, 1998.
32. Sharma DN, Chander S, Gairola M, et al: Medical disorders associated with endometrial carcinoma. J Assoc Physicians India 49: 630-633, 2002.